Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinicopathological Characteristics and A20 (TNFAIP3) Mutation In Primary Thyroid Lymphoma

Yasuko Hamada, MD, Mariko Ishibashi, PhD, Toshio Asayama, MD, Namiko Okuyama, MD, Asaka Kondo, MD, PhD, Keiichi Moriya, MD, PhD, Hideya Hyodo, MD, PhD, Takehito Igarashi, MD, PhD, Hiroyuki Onose, MD, PhD, Norio Yokose, MD, PhD, Sakae Tanosaki, MD, PhD, Kazuo Shimizu, MD, PhD, Hideto Tamura, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 4320.

https://doi.org/10.1182/blood.V122.21.4320.4320

Published: 2013

Journal Articles

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

Yasuko Hamada, MD, Hideto Tamura, MD, PhD, Mariko Ishibashi, PhD, Namiko Okuyama, MD, Asaka Kondo, MD, PhD, Keiichi Moriya, MD, PhD, Kiyoyuki Ogata, MD, PhD, Keiji Kakumoto, Yoshihide Miyazaki, Akira Matsuda, MD, PhD, Kaoru Tohyama, MD, PhD, Yasunori Ueda, MD, PhD, Mineo Kurokawa, MD, PhD, Hirohiko Shibayama, Nobuhiko Emi, MD, PhD, Kinuko Mitani, M.D., Ph.D., Tomoki Naoe, MD, PhD, Haruo Sugiyama, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 2799.

https://doi.org/10.1182/blood.V122.21.2799.2799

Published: 2013

Journal Articles

B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior

Hideto Tamura, MD, PhD, Mariko Ishibashi, PhD, Taishi Yamashita, PhD, Asaka Kondo, MD, PhD, Namiko Okuyama, MD, Hideya Hyodo, MD, PhD, Yasuko Hamada, MD, Kazuo Dan, MD, PhD, Lieping Chen, MD, PhD, Kiyoyuki Ogata

Blood (2011) 118 (21): 474.

https://doi.org/10.1182/blood.V118.21.474.474

Published: 2011

Journal Articles

B7.2 and B7-H2 Molecules Stimulate Proliferation of Myeloma Cells and Inhibit Anti-Myeloma Immune Responses.

Taishi Yamashita, Hideto Tamura, MD, Chikako Sato, Asaka Kondo, MD, Takashi Tsuji, PhD, Kazuo Dan, MD, Kiyoyuki Ogata, MD

Blood (2007) 110 (11): 3524.

https://doi.org/10.1182/blood.V110.11.3524.3524

Published: 2007

Journal Articles

Expression of Functional B7-H1 Molecules on Blasts from Myelodysplastic Syndromes.

Asaka Kondo, MD, Taishi Yamashita, Hideto Tamura, MD, Chikako Sato, Risa Jo, Takashi Tsuji, PhD, Kazuo Dan, MD, Kiyoyuki Ogata, MD

Blood (2007) 110 (11): 2429.

https://doi.org/10.1182/blood.V110.11.2429.2429

Published: 2007

NARROW

Clinicopathological Characteristics and A20 (TNFAIP3) Mutation In Primary Thyroid Lymphoma

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior

B7.2 and B7-H2 Molecules Stimulate Proliferation of Myeloma Cells and Inhibit Anti-Myeloma Immune Responses.

Expression of Functional B7-H1 Molecules on Blasts from Myelodysplastic Syndromes.

Email alerts

ASH Publications

American Society of Hematology

Clinicopathological Characteristics and A20 (TNFAIP3) Mutation In Primary Thyroid Lymphoma

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior

B7.2 and B7-H2 Molecules Stimulate Proliferation of Myeloma Cells and Inhibit Anti-Myeloma Immune Responses.

Expression of Functional B7-H1 Molecules on Blasts from Myelodysplastic Syndromes.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only